New synergistic effects of inhibition of Histone deacetylases 8 and 10 as well as ALK as treatment options in neuroblastoma.
The invention shows that a combination of HDAC and ALK inhibitors for tumortherapy is surprisingly synergistic and can additionally overcome single substance drug resistance.
Further information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles

Gas Adsorption Insights on Platinum and Gold Nanotunnels
Understanding gas diffusion in nanoscale voids key to new gas technologies Tokyo, Japan – Researchers from Tokyo Metropolitan University have elucidated how hydrogen and carbon monoxide is adsorbed into solids…

Pandemic Resilience: How Playfulness Boosted Well-Being
Adults with high levels of playfulness showed strong resilience during the COVID-19 pandemic compared to less playful individuals, new research shows. The study led by Xiangyou “Sharon” Shen of Oregon…

Using Electroencephalography to Improve Language Disorder Treatments
Researchers work towards an inexpensive and portable solution for treating aphasia Electroencephalography (EEG) may offer a more accessible alternative to functional magnetic resonance imaging (fMRI) for guiding transcranial direct current…